SKŘIČKOVÁ, Jana, Renata CHLOUPKOVÁ, Karel HEJDUK, Miloš PEŠEK, Vítězslav KOLEK, L KOUBKOVÁ, Jaromír ROUBEC, M ČERNOVSKÁ, František SALAJKA, J KKREJČÍ, L HAVEL, Marcela TOMÍŠKOVÁ, Monika ŠATÁNKOVÁ, Andrea BENEJOVÁ, I GRYGÁRKOVÁ, Michal HRNČIARIK, M ZEMANOVÁ, Dimka SIXTOVÁ, Zdeněk MERTA, P OPÁLKA and J KREJČÍ. Tyrosine-kinase inhibitors (TKI) in first-line treatment of patients with non-small cell lung cancer (NSCLC) - real life data from Czech republik. In European respiratory Journal 2018. In ERS international Congres 2018, European respiratory society Paris, France. 2018.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Tyrosine-kinase inhibitors (TKI) in first-line treatment of patients with non-small cell lung cancer (NSCLC) - real life data from Czech republik. In European respiratory Journal 2018
Authors SKŘIČKOVÁ, Jana, Renata CHLOUPKOVÁ, Karel HEJDUK, Miloš PEŠEK, Vítězslav KOLEK, L KOUBKOVÁ, Jaromír ROUBEC, M ČERNOVSKÁ, František SALAJKA, J KKREJČÍ, L HAVEL, Marcela TOMÍŠKOVÁ, Monika ŠATÁNKOVÁ, Andrea BENEJOVÁ, I GRYGÁRKOVÁ, Michal HRNČIARIK, M ZEMANOVÁ, Dimka SIXTOVÁ, Zdeněk MERTA, P OPÁLKA and J KREJČÍ.
Edition ERS international Congres 2018, European respiratory society Paris, France, 2018.
Other information
Type of outcome Conference abstract
Confidentiality degree is not subject to a state or trade secret
Changed by Changed by: prof. MUDr. Jana Skřičková, CSc., učo 1808. Changed: 20/2/2019 14:52.
PrintDisplayed: 20/6/2024 20:59